Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Open-Label AA4500 (Collagenase Clostridium Histolyticum) in Men with Peyronie's Disease
2010-022921-13Phase 3Completed
- Sponsor
- Auxilium UK Limited
- Start
- Nov 2010
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of collagenase clostridium histolyticum in Peyronie's disease, sponsored by Auxilium UK Limited. Primary endpoint: Primary safety and effectiveness endpoints. Started Nov 2010; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Peyronie's disease
Beyond the preview
Go deeper on 2010-022921-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022921-13.